Dealing with frequent hitters in drug discovery: a multidisciplinary view on the issue of filtering compounds on biological screenings

dc.creatorDantas, Rafael Ferreira
dc.creatorEvangelista, Tereza Cristina Santos
dc.creatorNeves, Bruno Junior
dc.creatorSenger, Mario Roberto
dc.creatorAndrade, Carolina Horta
dc.creatorFerreira, Sabrina Baptista
dc.creatorSilva Junior, Floriano Paes
dc.date.accessioned2020-08-08T20:59:08Z
dc.date.accessioned2023-09-05T11:50:49Z
dc.date.available2020-08-08T20:59:08Z
dc.date.available2023-09-05T11:50:49Z
dc.date.created2020-08-08T20:59:08Z
dc.date.issued2019
dc.identifierDANTAS, Rafael Ferreira et al. Dealing with frequent hitters in drug discovery: a multidisciplinary view on the issue of filtering compounds on biological screenings. Expert Opinion on Drug Discovery, p. 1-15, 2019.
dc.identifier1746-0441
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/42603
dc.identifier10.1080/17460441.2019.1654453
dc.identifier1746-045X
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8643396
dc.languageeng
dc.publisherTaylor & Francis
dc.rightsrestricted access
dc.titleDealing with frequent hitters in drug discovery: a multidisciplinary view on the issue of filtering compounds on biological screenings
dc.typeArticle


Este ítem pertenece a la siguiente institución